Applied DNA Sciences, Inc.

BRIEF

published on 04/01/2025 at 15:50, 2 days 6 hours ago

Applied DNA repositionne le test TR8 PGx après l'annonce de la FDA

ADN Appliqué Tests Génétiques Fluoropyrimidine Test TR8 PGx Variantes Du DPYD
BRIEF

published on 04/01/2025 at 15:50, 2 days 6 hours ago

Applied DNA Repositions TR8 PGx Test Post-FDA Announcement

Genetic Testing Applied DNA TR8 PGx Test DPYD Variants Fluoropyrimidine
PRESS RELEASE

published on 04/01/2025 at 15:45, 2 days 6 hours ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
Applied DNA Sciences announces repositioning of TR8™ PGx testing service to offer tailored subpanels targeting genetic variants correlated with DPD enzyme deficiencies in cancer patients, following recent FDA safety announcement

Genetic Testing Applied DNA Sciences Pharmacogenomics TR8 PGx FDA Safety Announcement
BRIEF

published on 09/11/2024 at 15:05, 6 months 22 days ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

PCR Technology Applied DNA Mpox Testing Clade I And II Health Diagnostics
BRIEF

published on 09/11/2024 at 15:05, 6 months 22 days ago

Applied DNA lance le service de test Mpox Clade I et Clade II

Technologie PCR Diagnostic De Santé ADN Appliqué Test Mpox Clades I Et II
PRESS RELEASE

published on 09/11/2024 at 15:00, 6 months 22 days ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service
Applied DNA Sciences expands clinical testing to include detection of Mpox Clade I and Clade II. ADCL, a NYSDOH CLEP-permitted laboratory, offers Linea Mpox Virus 1.0 Assay from Stony Brook, NY

Applied DNA Sciences Linea Mpox Virus 1.0 Assay Mpox Testing ADCL Clinical Laboratory
BRIEF

published on 08/23/2024 at 15:05, 7 months 11 days ago

Applied DNA Submits Validation Package to NYSDOH for Mpox Clade I Detection Expansion

Applied DNA Mpox Clade I NYSDOH Approval Validation Studies Linea Assay
BRIEF

published on 08/23/2024 at 15:05, 7 months 11 days ago

Applied DNA soumet un dossier de validation au NYSDOH pour l'extension de la détection de Mpox Clade I

ADN Appliqué Clade I De Mpox Études De Validation Dosage De La Ligne Approbation Du NYSDOH
PRESS RELEASE

published on 08/23/2024 at 15:00, 7 months 11 days ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
Applied DNA Sciences expands Linea Mpox Virus 1.0 Assay to detect mpox clade I and clade Ib in addition to clade II with 100% homology. NYSDOH review ongoing

Applied DNA Sciences PCR-based DNA Technologies Mpox Clade I Linea Mpox Virus 1.0 Assay NYSDOH Review
BRIEF

published on 08/19/2024 at 21:30, 7 months 15 days ago

Applied DNA cherche à obtenir l'approbation d'une utilisation élargie du test Linea Mpox Virus 1.0

Mpox ADN Appliqué Clade I District De Columbia De New York Approbation Des Analyses

1 2 ... 8

Published on 04/03/2025 at 15:05, 7 hours 38 minutes ago

Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 7 hours 43 minutes ago

Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 7 hours 43 minutes ago

UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/03/2025 at 15:00, 7 hours 43 minutes ago

Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico
Published on 04/03/2025 at 14:30, 8 hours 13 minutes ago

Dominari Holdings Highlights Supporting American Companies

View all ACCESSWIRE

Published on 04/03/2025 at 19:37, 3 hours 6 minutes ago

Changes to Sub-Funds
Published on 04/03/2025 at 19:32, 3 hours 10 minutes ago

Changes to Sub-Funds
Published on 04/03/2025 at 19:22, 3 hours 21 minutes ago

Changes to Sub-Funds
Published on 04/03/2025 at 19:11, 3 hours 32 minutes ago

Changes to Sub-Funds
Published on 04/03/2025 at 19:00, 3 hours 43 minutes ago

Changes to Sub-Funds

View all EQS

Published on 04/03/2025 at 18:46, 3 hours 57 minutes ago

Monthly disclosure of the total number of shares and voting rights - March 2025
Published on 04/03/2025 at 18:46, 3 hours 57 minutes ago

Déclaration mensuelle des actions et droits de vote – Mars 2025
Published on 04/03/2025 at 18:00, 4 hours 43 minutes ago

LDC : Chiffre d'affaires 2024-2025 : 6,3 milliards d’euros, au-delà des objectifs.
Published on 04/03/2025 at 17:45, 4 hours 58 minutes ago

CDA - Acquisition of Belantis park
Published on 04/03/2025 at 17:45, 4 hours 58 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

News